Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.

ABSTRACT:

Objectives

Low rates of participation in cancer clinical trials are commonly reported, raising concerns about missed opportunities to engage patients in treatment trials. We reviewed eligibility for and enrollment in pancreatic cancer clinical trials for patients seen at a National Cancer Institute (NCI)-designated cancer center during 1 year, to calculate participation rates with detailed information to determine the best-case participation rate.

Materials and methods

This retrospective cohort study used the Abramson Cancer Center Cancer Registry, clinical trial protocols, and electronic medical records (EMRs) to determine eligibility for all available pancreatic cancer clinical trials. Patient characteristics and reasons for ineligibility were abstracted from EMRs. We then

SUBMITTER: Guerra CE 

PROVIDER: S-EPMC8140996 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature